pharma
Life Sciences Scotland appoints two MSPs to their Industry Leadership Group
September 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Scotland, Scotland, economic development, pharma
Life Sciences Scotland, an organisation focused towards developing the life sciences industry in the northernmost constituent country of the United …
Kenneth Frazier to continue as CEO as MSD rescinds mandatory retirement policy
September 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kenneth Frazier, MSD, pharma
MSD has pitched a curveball with the news that the company has rescinded its policy mandating that Chief Executive Officers …
The October 2018 issue of Pharmafocus is available to read online now!
September 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma
The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …
Alexion’s Soliris almost entirely eliminates relapses in rare neuromyelitis optica spectrum disorder
September 26, 2018Research and Development Alexion, neuromyelitis optica spectrum disorder, pharma, rare disease, soliris
Alexion has revealed new Phase 3 findings for Soliris (eculizumab), showing the drug met its primary endpoint in the treatment …
Roche’s Tecentriq+chemo combo shows first-line benefit in small cell lung cancer
September 26, 2018Research and Development Cancer, Combo, Roche, chemotherapy, lung cancer, pharma, tecentriq
Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide chemotherapy …
AstraZeneca chalks up European approval for Imfinzi in locally advanced, unresectable lung cancer
September 25, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MedImmune, NSCLC, lung cancer, pharma
AstraZeneca and its global biologics R&D arm MedImmune have announced the approval by the European Commission of Imfinzi (durvalumab) as …
Sarepta’s Exondys 51 hit with negative CHMP opinion in Duchenne muscular dystrophy
September 24, 2018Research and Development, Sales and Marketing CHMP, Duchenne Muscular Dystophy, EMA, Europe, Exondys 51, pharma, sarepta
Sarepta Therapeutics has been rocked by a hurdle in its pursuit of regulatory approval in Europe, as the company revealed …
AstraZeneca’s Farxiga cuts heart risk in type 2 diabetes patients
September 24, 2018Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma
AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings …
EU approval for Mylan and Fujifilm’s Humira biosimilar
September 21, 2018Medical Communications, Sales and Marketing EU, Europe, Humira, Mylan, biosimilar, pharma
The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing authorisation to …
A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated
September 20, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma
Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …
Astellas’ chronic kidney drug shows superiority at Phase 3
September 20, 2018Research and Development Astellas, chronic kidney disease, pharma, roxadustat
Astellas has revealed new Phase 3 data for roxadustat in the treatment of chronic kidney disease (CKD) in patients with …
FDA greenlights Teva’s migraine drug Ajovy in two dosage options
September 20, 2018Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma
Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …
Almirall’s Ilumetri scores EU approval in chronic plaque psoriasis
September 19, 2018Research and Development, Sales and Marketing Almirall, EADV 2018, Ilumetri, pharma, psoriasis
Hot on the heels of the European Academy of Dermatology and Venereology Congress (EADV) 2018 where psoriasis took centre stage, …
Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected
September 19, 2018Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma
Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …
Cancer Research UK announces new £14m research hub in London
September 18, 2018Manufacturing and Production, Research and Development CRUK, Cancer, pharma
Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
